• OS Therapies raised approximately $7.2 million in gross proceeds at the initial closing of a warrant exercise inducement and exchange offer.
• Seven holders exercised or pre-funded existing warrants covering 5,517,253 shares at $1.30 per share, or $1.299 per share for pre-funding.
• Participating holders received new common stock purchase warrants covering 5,517,253 shares at an exercise price of $1.40 per share.
• The offer expires at 11:59 p.m. Eastern time on October 30, 2026, unless extended or terminated earlier.
• Net proceeds will support Herlystic regulatory filings, commercial preparations and general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OS Therapies Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610190830NEWSFILECNPR____20261019_319689_1) on October 19, 2026, and is solely responsible for the information contained therein.